Endogenous axon guiding chemorepulsant semaphorin-3F inhibits the growth and metastasis of colorectal carcinoma

Clinical Cancer Research

Volumn 17, Issue 9, 2011, Pages 2702-2711

  Wu, Feng ^a   Zhou, Qi ^a   Yang, Jing ^a   Duan, Guang Jie ^a   Ou, Juan Juan ^a   Zhang, Rong ^a   Pan, Feng ^a   Peng, Qiu Ping ^a   Tan, Hong ^a   Ping, Yi Fang ^a   Cui, You Hong ^a   Qian, Cheng ^a   Yan, Xiao Chu ^a   Bian, Xiu Wu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; MESSENGER RNA; SEMAPHORIN 3F; SMALL INTERFERING RNA; TETRAZOLIUM; VITRONECTIN RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CELL ADHESION; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AXONS; CARCINOMA; CELL LINE, TUMOR; CELL MIGRATION INHIBITION; CELL PROLIFERATION; CHEMOTACTIC FACTORS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM METASTASIS; NERVE TISSUE PROTEINS; RNA, SMALL INTERFERING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79955514351     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-0839     Document Type: Article

References (42)

1. Heide J, Kr€ull A, Berger J. Extracapsular spread of nodal metastasis as a prognostic factor in rectal cancer. Int J Radiat Oncol Biol Phys 2004;58:773-8. (Pubitemid 38221134)
2. Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer 2003;98:413-23. (Pubitemid 36828469)
3. Fukunaga S, Maeda K, Noda E, Inoue T, Wada K, Hirakawa K. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer. Oncology 2006;71:204-11.
4. Favier B, Alam A, Barron P, Bonnin J, Laboudie P, Fons P, et al. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survivalandmigration. Blood2006;108:1243-50.
5. Giger RJ, Urquhart ER, Gillespie SK, Levengood DV, Ginty DD, Kolodkin AL. Neuropilin 2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Neuron 1998;21:1079-92. (Pubitemid 29018077)
6. Chen H, Chédotal A, He Z, Goodman CS, Tessier-Lavigne M. Neuropilin 2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 1997;19:547-59. (Pubitemid 27430744)
7. Chen H, He Z, Bagri A, Tessier-Lavigne M. Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins. Neuron 1998;21:1283-90. (Pubitemid 29022531)
8. Gammill LS, Gonzalez C, Gu C, Bronner-Fraser M. Guidance of trunk neural crest migration requires neuropilin 2/semaphorin 3F signaling. Development 2006;133:99-106. (Pubitemid 43169324)
9. Gammill LS, Gonzalez C, Bronner FM . Neuropilin 2/semaphorin 3F signaling is essential for cranial neural crest migration and trigeminal ganglion condensation. Dev Neurobiol 2007;67:47-56. (Pubitemid 46146139)
10. Fukahi K, Fukasawa M, Neufeld G, Itakura J, Korc M. Aberrant expression of neuropilin-1 and -2 in human pancreatic cancer cells. Clin Cancer Res 2004;10:581-90. (Pubitemid 38173997)
11. Lantuejoul S, Constantin B, Drabkin H, Brambilla C, Roche J, Brambilla E. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. J Pathol 2003;200:336-47. (Pubitemid 36827308)
12. Bielenberg DR, Hida Y, Shimizu A, Kaipainen A, Kreuter M, Kim CC, et al. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest 2004;114:1260-71. (Pubitemid 40385297)
13. Caunt M, Mak J, Liang WC, Stawicki S, Pan Q, Tong RK, et al. Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 2008;13:331-42. (Pubitemid 351446192)
14. Kusy S, Nasarre P, Chan D, Potiron V, Meyronet D, Gemmill RM, et al. Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. Neoplasia 2005;7:457-65. (Pubitemid 40791865)
15. Tse C, Xiang RH, Bracht T, Naylor SL. Human SEMA3B located at 3p21.3 suppresses tumor formation in an adenocarcinoma cell lines. Cancer Res 2002;62:542-6. (Pubitemid 34106429)
16. Nasarre P, Kusy S, Constantin B, Castellani V, Drabkin HA, Bagnard D, et al. Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. Neoplasia 2005;7:180-9. (Pubitemid 40315995)
17. Morikawa K, Walker SM, Jessup JM, Fidler IJ. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 1988;48:1943-8.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-8. (Pubitemid 34164012)
19. Gray MJ, Van Buren G, Dallas NA, Xia L, Wang X, Yang AD, et al. Therapeutic targeting of Neuropilin-2 on colorectal carcinoma cells implanted with murine liver. J Natl Cancer Inst 2008;100:109-20. (Pubitemid 351480563)
20. Wang JF, Zhang XF, Groopman JE. Stimulation of a9b1 integrin induces tyrosine phosphorylation of VEGF receptor-3 and modulates cell migration. J Biol Chem 2001;276:41950-7.
21. Kruger RP, Aurandt J, Guan KL. Semaphorin command cells to move. Nat Rev Mol Cell Biol 2005;6:789-800.
22. Comoglio PM, Tamagnone L, Giordano S. Invasive growth a twoway street for semaphorin signalling. Nat Cell Biol 2004;6: 1155-7. (Pubitemid 39625112)
23. Xiang RH, Hensel CH, Garcia DK, Carlson HC, Kok K, Daly MC, et al. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics 1996;32: 39-48.
24. Sekido Y, Bader S, Latif F, Chen JY, Duh FM, Wei MH, et al. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci U S A 1996;93:4120-5. (Pubitemid 26146727)
25. Tomizawa Y, Sekido Y, Kondo M, Gao B, Yokota J, Roche J, et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene Sema3B. Proc Natl Acad Sci U S A 2001;98:13954-9. (Pubitemid 33116005)
26. Neufeld G, Shraga-Heled N, Lange T, Guttmann-Raviv N, Herzog Y, Kessler O. Semaphorins in cancer. Front Biosci 2005;10:751-60.
27. Nasarre P, Constantin B, Rouhaud L, Harnois T, Raymond G, Drabkin HA, et al. Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. Neoplasia 2003;5:83-92. (Pubitemid 36151061)
28. Tse C, Xiang RH, Bracht T, Naylor SL. Human SEMA3B located at 3p21.3 suppresses tumor formation in an adenocarcinoma cell lines. Cancer Res 2002;62:542-6. (Pubitemid 34106429)
29. Kessler O, Shraga-Heled N, Lange T, Gutmann-Raviv N, Sabo E, Baruch L, et al. Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res 2004:64:1008-15. (Pubitemid 38176904)
30. Kigel B, Varshavsky A, Kessler O, Neufeld G. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. PLoS One 2008;3:e3287.
31. Narazaki M, Segarra M, Tosato G. Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. Blood 2008;111:4126-36.
32. Narazaki M, Tosato G. Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood 2006;107:3892-901. (Pubitemid 43726793)
33. Xiang R, Davalos AR, Hensel CH, Zhou XJ, Tse C, Naylor SL. Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res 2002;62:2637-43. (Pubitemid 34462746)
34. Catalano A, Caprari P, Rodilossi S, Betta P, Castellucci M, Casazza A, et al. Cross-talk between VEGF and Semaphorin 3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J 2004;18:358-60.
35. Takahashi T, Fournier A, Nakamura F, Wang LH, Murakami Y, Kalb RG, et al. Plexin-neuropilin-1 complexes form functional semaphorin- 3A receptors. Cell 1999;99:59-69. (Pubitemid 29468630)
36. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI anchored semaphorins in vertebrates. Cell 1999;99:71-80. (Pubitemid 29468631)
37. Takahashi T, Strittmatter SM. PlexinA1 autoinhibition by the plexin sema domain. Neuron 2001;29:429-39. (Pubitemid 32206481)
38. Toyofuku T, Yoshida J, Sugimoto T, Zhang H, Kumanogoh A, Hori M, et al. FARP2 triggers signals for Sema3A mediated axonal repulsion. Nature Neurosci 2005;8:1712-9. (Pubitemid 41683199)
39. Tadokoro S, Shattil SJ, Eto K, Tai V, Liddington RC, de Pereda JM, et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science 2003;302:103-6. (Pubitemid 37210697)
40. Nguyen QD, Rodrigues S, Rodrigue CM, Rivat C, Grijelmo C, Bruyneel E, et al. Inhibition of vascular endothelial growth factor (VEGF) 165 and semaphorin 3A mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts. Mol Cancer Ther 2006;5:2070-7. (Pubitemid 44336579)
41. Yuan L, Moyon D, Pardanaud L, Bréant C, Karkkainen MJ, Alitalo K, et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 2002;129:4797-806. (Pubitemid 35282411)
42. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A 2001;98:12677-82. (Pubitemid 33020005)